Abbott introduces OneLab.

‘No matter where they are located, laboratories around the world all talk about common challenges – increasing check loads, staff shortages and mounting pressure to accomplish more with less while improving quality,’ stated Ulf Oesinghaus, deputy pharmacy manager, laboratory director of strategic purchasing, University of Medication Gottingen, Germany. ‘To address challenges posed by price pressures and personnel shortages, labs desire informatics solutions that help them expedite test result processing and transmit clinical information clearly and rapidly to physicians.There are no trearments indicated to treat the currently chronic neurological deficits connected with stroke, said Ron Cohen, M.D., Acorda Therapeutics’ President and CEO. Preclinical data have demonstrated that dalfampridine can improve functional deficits resulting from ischemic stroke, providing a strong basis because of this first clinical trial in people who have post-stroke deficits. This proof-of-concept study will measure the tolerability and protection of AMPYRA in people with stable post-stroke deficits after an ischemic stroke.